ShRNA sequence for targeted silencing of BRAF gene and application of shRNA sequence
A technology of targeted silencing and gene sequence, applied in the field of biomedicine, can solve the problem of short time to play, achieve huge social and economic benefits, inhibit human fibroblast aging, and have strong specificity.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0018] Example 1: Construction of lentiviral vector
[0019] Obtain the mRNA sequence of the BRAF gene (NM_004333.6) according to the GenBank database (http: / / www.ncbi.nlm.nih.gov / genbank), and select the target sequence according to the shRNA design principle. These two oligonucleotides The sequences of the chains are respectively marked as BRAF-1 and BRAF-2; wherein, the target sequence of BRAF-1 is shown in SEQ ID NO.1, namely: 5´-Tcggctgcggaccctgccatt-3´ (the corresponding coding region is 335-355 nucleotide position); the target sequence of BRAF-2 is shown in SEQ ID NO.2, namely: 5´-AtctccaggacctcagCGAGA-3´ (the corresponding coding region is the 1479-1499 nucleotide position).
[0020] Use the primer software to design the shRNA sequence, and perform sequence alignment on the NCBI website to verify its specificity. According to the target sequence BRAF-1, design and synthesize the following oligonucleotide sequence: the sense strand of shBRAF-1 shBRAF-1- F is shown in S...
Embodiment 2
[0022] Example 2: Preparation of cell lentivirus and transfection of cells with lentivirus
[0023] The lentivirus was packaged according to the instructions of Lipofectamine 2000 reagent. The cells transfected with the two lentiviral vectors prepared in Example 1 were used as the experimental group, and the cells transfected with the pLKO.1-TRC lentiviral empty vector were used as the control group;
[0024] Add 0.75 μg pLP1, 0.35 μg pLP2, 0.49 μg pLPSVG, and 0.61 μg lentiviral vector pLKO.1-TRC-shBRAF-1 to 0.5 mL low-serum OPTI-MEM medium, mix gently, and incubate at room temperature for 5 min, to obtain liquid A, ready to use.
[0025]Take 9 μL of liposome Lipofectmine 2000 and add it to 0.5 mL of OPTI-MEM medium, mix gently, and place at room temperature for 5 minutes to obtain solution B, which is ready for use.
[0026] Mix solution A and solution B at a ratio of 1:1 to obtain a mixed solution, and incubate at room temperature for 20 min; gently and thoroughly mix the ...
Embodiment 3
[0029] Example 3: Detection of protein expression level of BRAF gene in IMR90 cells by Western blotting.
[0030] The virus-infected IMR90 cells were collected, the total protein was extracted, the protein concentration was determined, the protein was denatured, and the gel was transferred to the membrane. After the membrane was blocked with 5% skimmed milk for 1 h, the BRAF antibody and β-actin antibody were used to incubate overnight, and then pepper Incubate the goat anti-mouse antibody against root peroxidase for 1 h at room temperature. After antibody incubation, wash the membrane with TBS-T solution at room temperature for 3 times, 4 min each time, and finally place the membrane in a darkened cassette and take it to the darkroom. During exposure, the film is fixed on the film, and the protein bands will be printed on the film under the action of the luminescent solution and the developing solution. The surviving IMR90 cells in the experimental group and the control group...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap